Council Decision 2026/0029 (NLE) lets the EU submit a proposal to the Stockholm Convention to ban or restrict the dangerous flame‑retardant TBPH, protecting people and the planet.

This council decision is a resolution that adds Sweden’s 2 billion‑SEK (about 147 million EUR) non‑repayable aid to the Ukraine Plan, putting the money into the eighth instalment and outlining a schedule of reforms and investments for Ukraine from 2024 to 2027.

The EU will adopt a decision to support adding three new drugs to the UN controlled lists, which will automatically bring them under EU law and give the EU a unified voice at the UN meeting.

This resolution tweaks Ireland’s Recovery and Resilience Plan by dropping or updating 20 measures, reshuffling deadlines, keeping the full €1.15 billion EU funding, and adding a strict monitoring system to make sure the plan stays on track.

The European Council updated the Netherlands’ Recovery and Resilience Plan, tweaking 34 measures, adding two new ones, keeping the EU money the same, and adjusting the budget and timeline so the plan stays on track.

The European Biotech Act is a law that simplifies rules for biotech, helps companies get money and skills, and keeps products safe, so the EU can grow its biotech industry faster and more securely.

The EU Food & Feed Safety Simplification Proposal 2025 is a new regulation that cuts paperwork, speeds up approvals, and keeps safety high, saving money for businesses and farmers.

The resolution updates EU medical device safety rules to make them less expensive and time-consuming for companies while keeping devices safe, so patients can get the medical equipment they need faster and small companies won't go out of business trying to follow complicated requirements.

This Directive updates EU rules on genetically modified microbes and organ processing to make approvals easier for companies and hospitals, adding new low‑risk categories, simplifying paperwork, and ensuring safety for new preservation methods.

The European Biotech Act is a new rule that speeds up approvals, brings more money, and cuts red‑tape so EU biotech companies can develop and sell medicines and foods faster.

This resolution cuts the paperwork for battery makers and farmers by simplifying rules, making battery packs safer, and letting countries decide what data to collect.